Fig. 5From: Enhancing diagnosis and treatment of superior cluneal nerve entrapment: cadaveric, clinical, and ultrasonographic insightsA Visual analogue scale of pain and (B) Oswestry Disability Index at baseline, post-injection 1st and 3rd months for each group. Group 1, who did not respond to the initial treatment; Group 2, who initially responded to treatment but experienced symptom recurrence; and Group 3, who responded well to treatment and did not experience symptom recurrenceBack to article page